Pharma Japan: US VC Coalition Urges Japan to Rethink Drug Pricing, Labor Rules
Pharma Japan covered Incubate Coalition Japan’s recommendations during the October delegation. The coalition urged Japan to take a broader approach to revitalizing its drug discovery sector, with reforms spanning drug pricing, research funding and labor regulations to make the country more attractive to global investors. The story features RA Capital Management Partner Josh Resnick and Incubate Executive Director John Stanford.

Comments